Tue.Jan 16, 2024

article thumbnail

Pharmacist Interventions May Improve Clinical Outcomes of Patients With T2D

Drug Topics

By getting involved in patient care, pharmacists can help alleviate the burdens associated with the self-management of type 2 diabetes (T2D).

article thumbnail

To Crush or Not to Crush: That is the Medication Administration Question

Pharmacy Times

Pharmacists are well suited to identify patients with dysphagia and educate patients and caregivers on when and how to safely crush and administer medication.

158
158
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Real-Time CGM Superior to Intermittently Scanned CGM in T1D, Analysis Finds

Drug Topics

Real-time continuous glucose monitoring (CGM) demonstrated benefits associated with time in range, hypoglycemia, and hyperglycemia in patients with type 1 diabetes (T1D).

186
186
article thumbnail

FDA Approves IgG-Hyaluronidase Recombinant for the Treatment of Adult Patients With CIDP

Pharmacy Times

Previously, IgG-hyaluronidase recombinant was approved by the FDA in 2014 for the treatment of primary immunodeficiency in adult patients and has expanded to include some pediatric patients.

FDA 145
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

COVID-19 Vaccination Effective at Preventing Long COVID in Children, Adolescents

Drug Topics

Within a 12-month time frame, adjusted vaccine effectiveness against diagnosed long and probable long COVID was 41.7% and 35.4%, respectively.

Vaccines 193
article thumbnail

Community Pharmacists Have Distinct Role in Fall Prevention for Patients

Pharmacy Times

Pharmacists play a significant role in early identification, continuous monitoring, and interventions to help minimize the risk of falls in older adults.

156
156

More Trending

article thumbnail

AHA: Snow Shoveling Increases Risk of Heart Attack, Sudden Cardiac Arrest

Pharmacy Times

An American Heart Association scientific statement cautions individuals with known or suspected cardiovascular disease or risk factors against shoveling snow.

139
139
article thumbnail

STAT+: FDA expands approval of CRISPR-based medicine to treat beta thalassemia

STAT

The Food and Drug Administration on Tuesday approved a CRISPR-based medicine to treat beta thalassemia, an inherited blood disorder. It’s the same potentially curative therapy cleared by the FDA in December to treat sickle cell disease. The expanded approval of the therapy, called Casgevy, was widely expected but came two months ahead of the FDA’s decision deadline, known as a PDUFA date.

FDA 142
article thumbnail

Proper Use of Automation in Hazardous Drug Compounding Pharmacies

Pharmacy Times

Although robotics can be instrumental in assuring sterility and reducing the overall number of potential hazardous drug exposure events, certain tasks require vigilant oversight.

article thumbnail

STAT+: Many doctors are in the dark about how FDA approves devices and drugs, survey finds

STAT

In her final presentation for health policy class at the University of Chicago, first-year medical student Robin Ji informed her classmates that the Food and Drug Administration does not require randomized controlled trials of most medical devices. Her peers’ immediate reaction was disbelief. “One classmate kept asking me, are you sure?

FDA 140
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Morgan Health: 3 things employers should focus on to manage GLP-1s

Fierce Healthcare

Demand remains high for GLP-1 drugs, and the experts at Morgan Health are aiming to support employers in managing that interest with a new report. | Demand remains high for GLP-1 drugs, and the experts at Morgan Health are aiming to support employers in managing that interest with a new report.

130
130
article thumbnail

STAT+: Could private equity be the future of private practice? A new lobbying group thinks so

STAT

Private equity gets a bad rap in health care. But some doctors see that kind of cash and consolidation as the only way for their practices to survive — and now, they’re taking that message to Washington. Lower pay, difficult negotiations with insurance companies, regulatory requirements from both government and commercial payers, expensive and inefficient IT systems, and the challenge of competing against hospital systems have created a “cascade of problems that seem like th

Insurance 135
article thumbnail

‘Medicine is going personalised’: Moderna’s UK boss on the coming vaccine revolution

The Guardian - Pharmaceutical Industry

Darius Hughes was a key figure in Pfizer’s pioneering Covid vaccine drive. Now he has changed companies – and sees a big future for mRNA technology The man who launched Pfizer’s Covid-19 vaccine in the UK three years ago – when 90-year-old Margaret Keenan in Coventry became the first person in the world to receive one – is now overseeing the construction of a manufacturing and research centre in Oxfordshire for rival US jab maker Moderna.

Vaccines 129
article thumbnail

STAT+: Dewpoint Therapeutics cuts 15% of staff, acknowledges Merck, Pfizer broke off partnerships over buzzy science

STAT

Dewpoint Therapeutics, the buzziest startup trying to tackle a new field of biology called biomolecular condensates, laid off 15% of its staff on Tuesday and acknowledged that a pair of collaboration deals with pharma companies had fallen apart. The downsizing is temporary, CEO Ameet Nathwani told STAT. The company needed to hire new employees with expertise to help move the company’s first drugs into clinical trials and expand its AI capabilities.

127
127
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Innovaccer acquires customer engagement platform Cured to enhance patient experience

Fierce Healthcare

Innovaccer, maker of digital tools for providers, has acquired Cured, a digital marketing and customer relationship management [CRM] platform. | The strategic purchase adds more than 20 health systems and first-time digital health clients to Innovaccer’s current portfolio of customers.

127
127
article thumbnail

The state of Medicare Advantage, in one chart

STAT

You’re reading the web version of Health Care Inc.,  STAT’s weekly newsletter  following the flow of money in medicine.  Sign up  to get it in your inbox every Monday.  Hospitals want you to look here, not over there Hospital leaders took pains to draw investors’ attention to their sizable cash and investment reserves at JPM.

Hospitals 124
article thumbnail

Startup Rad AI taps Google's cloud tech, MedLM to streamline repetitive tasks for radiologists

Fierce Healthcare

Rad AI, a startup that developed an AI platform for radiology, is teaming up with Google to use its cloud and large language models to streamline workflows and reduce radiologists' administrative b | Rad AI is teaming up with Google to use its cloud and large language models to power up its AI-based radiology platform. The company's technology, made by radiologists for radiologists, aims to streamline workflows and reduce repetitive tasks.

122
122
article thumbnail

Vertex, CRISPR's gene-editing therapy Casgevy wins early FDA nod to treat beta thalassemia

Fierce Pharma

Vertex Pharmaceuticals and CRISPR Therapeutics have scored an FD | Vertex Pharmaceuticals and CRISPR Therapeutics have scored an FDA approval for their gene-editing therapy Casgevy (exa-cel) to treat transfusion-dependent beta thalassemia (TDT). The approval came more than two months ahead of the FDA's March 30 decision date.

FDA 121
article thumbnail

STAT+: Survey: Confusion over key requirements means clinical trials aren’t registered and results aren’t reported

STAT

More than half of those responsible for registering clinical trials and reporting results fail to do so over confusion about key requirements, according to a new survey that highlighted ongoing difficulties in achieving transparency surrounding study data. Specifically, 52% said their major challenges involved sorting out the types of clinical trials that must be registered, when a trial should be registered, and when and for which trials information from summary results must be submitted to a U

119
119
article thumbnail

GSK pumps £200M+ into UK manufacturing network to bolster commercial ambitions, API supply

Fierce Pharma

As British pharma giant AstraZeneca looks abroad to build new factories, GSK is sticking close to home, where it plans to plug hundreds of millions of pounds into the United Kingdom over the next t | As other British drugmakers like AstraZeneca look abroad to build new factories, GSK is sticking close to home, where it plans to plug hundreds of millions of pounds into the United Kingdom over the next two years.

115
115
article thumbnail

Opinion: BMI as a barrier to orthopedic surgery doesn’t make sense for patient health

STAT

I am getting bent out of shape over surgeons telling patients they cannot get a knee replacement because they are above a certain BMI cutoff. Here’s a familiar scenario: A patient with a high body weight and BMI limps down the hall to my exam room. “How have you been?” I ask. He sighs. “I still can’t get a new knee.

115
115
article thumbnail

Transformative trends with real-world data from early access programmes

pharmaphorum

In addition to bringing treatment and hope to patients without alternatives, early access programmes provide further information on a product’s safety and efficacy data in real-world conditions.

114
114
article thumbnail

Opinion: Cord blood banking sounds like a great idea — until you realize what it costs babies

STAT

If her social media accounts are any indication, model, cookbook author, television personality, and entrepreneur Chrissy Teigen is a wonderful mother. Many parents regard her as a role model. That’s why I found it disappointing to learn that Teigen is a spokesperson for the Cord Blood Registry, which advocates for the collection of umbilical cord blood at birth for future use.

113
113
article thumbnail

Washington State AG Bob Ferguson files lawsuit to block Kroger-Albertsons merger

Drug Store News

Washington State Attorney General Bob Ferguson filed a lawsuit to block the proposed Kroger-Albertsons merger, saying that it will severely limit shopping options for consumers.

111
111
article thumbnail

Health care negotiations on Capitol Hill are clear as mud

STAT

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine.  Sign up here  to receive it in your inbox on Tuesdays and Thursdays. Bertagnolli’s burgeoning NIH agenda Monica Bertagnolli is just two months into directing the $48 billion NIH, but she has a  laundry list of challenges ahead of her.

111
111
article thumbnail

Wages haven’t kept pace with premium hikes: study

Fierce Healthcare

Wages have not been able to offset the rising costs of premiums for workers with employer-sponsored coverage over the last three decades, with Black and Hispanic employers hit particularly hard by | The mean cumulative lost earnings from 1988 to 2019 due to increased premiums in employer-sponsored health plans come to $125,340 per family, according to a JAMA Network Open study.

111
111
article thumbnail

HRG’s five notable products from December

Drug Store News

HRG reviewed 13 products in the health category, 38 items in the wellness sector and 27 items in the beauty aisle to see which ones stood out as Products to Watch.

115
115
article thumbnail

Merck's Keytruda again bags industry-first cervical cancer nod—with limitation

Fierce Pharma

After crowning Keytruda as the first immunotherapy for advanced cervical cancer back in 2021, the FDA has awarded the drug another industry-first designation in an earlier stage of the tumor type. | After crowning Keytruda as the first immunotherapy for advanced cervical cancer back in 2021, the FDA has awarded the drug another industry-first designation in an earlier stage of the tumor type.

FDA 110
article thumbnail

Roche bags EU okay for subcutaneous Tecentriq

pharmaphorum

Roche’s Tecentriq has become the first PD-1/PD-L1 inhibitor to be cleared in the EU in a subcutaneous form that will make dosing easier for patients and healthcare providers

110
110
article thumbnail

How to use triamcinolone for eczema

The Checkup by Singlecare

Triamcinolone acetonide cream is one of the most popular topical steroids prescribed to treat eczema. If you have this condition, you may have been prescribed this medication and are looking to learn more. Or, perhaps you don’t have a prescription yet and are considering asking a healthcare professional if this medication is a good choice for you. Either way, you are probably looking for information about the best ways to use this Rx, how long you can use it, and what some potential side effects

article thumbnail

Prediction is very difficult, especially if it’s about the future

pharmaphorum

In a new episode of the pharmaphorum podcast, host Nicole Raleigh welcomes Carl Hansen, CEO of AbCellera, for a conversation on the discovery and acceleration of antibody therapeutics.

110
110
article thumbnail

Research grant applications open for UK pharmacists and pharmacy technicians

Hospital Pharmacy Europe

A number of grants from Pharmacy Research UK (PRUK) are now open for application, including full funding for a full-time PhD studentship. The PhD Studentship Award is being trialled in PRUK’s annual funding round for the first time in place of its Research Development Awards. It is designed to support the salary, tuition and research costs associated with undertaking a full-time or part-time PhD.

Hospitals 105
article thumbnail

Marshfield Clinic Health System furloughing 3% of staff following failed Essentia Health merger

Fierce Healthcare

Less than two weeks after the demise of its merger plans, Marshfield Clinic Health System has shared plans to furlough 3% of its roughly 12,000 employees. | The furloughs will "largely" impact non-patient-seeing departments, including leadership. The cost-saving measure comes as the rural nonprofit system reports a -5.8% operating margin for the first nine months of 2023.

105
105
article thumbnail

Takeda picks up 2nd FDA-approved indication for immune globulin treatment HyQvia

Fierce Pharma

The FDA has approved Takeda's HyQvia as a maintenance therapy for CIDP. It is the second indication for HyQvia, which was first endorsed in 2014.